Skip to Content

Tag: Home Infusion


News

In brief: AdaptHealth’s static revenue, bid program’s impact, AOM’s Western expansion 

November 6, 2024HME News Staff

PLYMOUTH MEETING, Pa. – AdaptHealth reported third quarter net revenue of $805.9 million compared to $804 million, an increase of 0.2% year over year.  Net income attributable to AdaptHealth was $22.9 million vs. a net loss of $454.1 million. Adjusted EBITDA was $164.3 million vs. $161.2 million, an increase of 1.9%  “I continue to be optimistic about the road ahead,” said Suzanne Foster, CEO. “We have identified growth opportunities, we are assembling a high...

AdaptHealth, AOM Infusion, Competitive Bidding, Financial Results, Home Infusion


Read Full Articlered right arrow icon

Also Noted

AOM strengthens presence out West 

November 5, 2024HME News Staff

ARLINGTON, Va. – AOM Infusion is expanding its presence in Arizona, Michigan and Washington. The company says it is committed to developing strong partnerships with local health care providers, health systems and payers across the Southwest, Pacific Northwest and Midwest. “We are really proud of the growth the company has experienced over the past year,” said Keyur Mehta, CEO of AOM Infusion. “Strengthening our presence in these regions and strategically adding ambulatory...

AOM Infusion, Home Infusion


Read Full Articlered right arrow icon

Also Noted

Providence health system, Compassus form JV 

October 29, 2024HME News Staff

RENTON, Wash., and BRENTWOOD, Tenn. - Providence, a nonprofit health system serving the western U.S., and Compassus, a provider of integrated home-based care services, have signed an agreement to form a joint venture for home health, hospice, community-based palliative care and private-duty caregiving services. Under the agreement, Compassus will manage operations for the joint venture, which will include 24 home health locations in Alaska, California, Oregon and Washington, and 17 hospice and palliative...

Compassus, Home Infusion, Joint Venture, Providence


Read Full Articlered right arrow icon

Also Noted

SDS Rx, Virtue Technologies simplifies delivery 

September 24, 2024HME News Staff

CLARK, N.J. – SDS Rx, a health care delivery and logistics company, has partnered with Virtue Technologies to offer a streamlined delivery management solution for home infusion and specialty pharmacies. The partnership allows SDS Rx to offer an integration with Virtue Technologies' logistics platform, VirtueScript, which is designed to optimize and automate delivery workflows for providers utilizing multiple delivery methods. "As part of our ongoing effort to integrate with key partners...

Home Infusion, SDS Rx, Virtue Technologies


Read Full Articlered right arrow icon

NHIA develops drug list 

Also Noted

NHIA develops drug list 

August 13, 2024HME News Staff

ALEXANDRIA, Va. – The National Home Infusion Association has developed a list of medications to serve as a reference when making site of care decisions for patients requiring intravenous or subcutaneous infusions. The list reflects current U.S. prescribing practices and was compiled from medication dispensing reports from home infusion providers and reviewed by NHIA’s Quality and Standards Committee. “Home infusion providers have special expertise in the assessment, coordination...

Home Infusion, National Home Infusion Association (NHIA)


Read Full Articlered right arrow icon

Also Noted

AlayaCare tapped by BioMatrix 

July 22, 2024HME News Staff

NEW YORK – AlayaCare, a global tech platform for home infusion businesses, has been tapped by BioMatrix to bring nursing and agency documentation all in one place, eliminating time spent on administrative tasks, such as faxing and manual uploads. “AlayaCare has all of the necessary nursing operations built into the software that will allow BioMatrix to continue to provide top-notch infusion nursing services,” said David Kinard, vice president of nursing at BioMatrix. “Documenting...

AlayaCare, BioMatrix, Home Infusion


Read Full Articlered right arrow icon

Specialty Providers

Investor buys BioMatrix 

June 25, 2024HME News Staff

SEATTLE – Frazier Healthcare Partners, a Seattle-based, health care-focused investment firm, has closed on its acquisition of BioMatrix Holdings, a Plantation, Fla.-based national provider of home infusion services.  Frazier is partnering with Ted and Kathee Kramm, two highly experienced industry executives in the home infusion market, to lead BioMatrix with Ted as CEO and Kathee as president. The Kramms began their careers as clinicians (pharmacist and nurse, respectively) and have...

BioMatrix, Frazier Healthcare Partners, Home Infusion, Investment


Read Full Articlered right arrow icon

PromptCare: ‘Stay away from the fads’ 

Specialty Providers

PromptCare: ‘Stay away from the fads’ 

June 7, 2024Theresa Flaherty, Managing Editor

NEW PROVIDENCE, N.J. – PromptCare’s recent acquisition of New Orleans-based Coastal Infusion Services will give the provider a blueprint to add ambulatory infusion suites to its offerings, says CEO Paul Jardina.  While PromptCare, which offers home infusion, specialty pharmacy and complex respiratory services, has had a limited number of infusion suites for the past several years, it hasn’t been a focus, he said.  “We thought they had done a really good job...

Home Infusion, Mergers & Acquisitions (M&A), PromptCare


Read Full Articlered right arrow icon

Specialty Providers

PromptCare expands nat’l footprint 

May 7, 2024HME News Staff

NEW PROVIDENCE, N.J. - PromptCare, a provider of at-home and alternate-site infusion therapy, has announced that Coastal Infusion Services, which has a presence throughout the southern U.S., is now part of its family of companies.  Coastal Infusion Services also cares for patients at six state-of-the-art ambulatory infusion suites (AISs) strategically located throughout southern Louisiana.   “This is a unique opportunity to combine two organizations with deeply experienced...

Home Infusion, Mergers & Acquisitions (M&A), PromptCare


Read Full Articlered right arrow icon

Also Noted

Soleo Health named partner for new drug

May 7, 2024HME News Staff

FRISCO, Texas – Soleo Health has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM manufactured by Kedrion Biopharma. RYPLAZIM is the first and only U.S. Food & Drug Administration-approved treatment for supporting the approximately 500 people in the U.S. affected by plasminogen deficiency type 1 (PLGD-1).  "We take pride in being among the few selected specialty pharmacy providers administering RYPLAZIM to PLGD-1 patients,” said Drew Walk, CEO...

Home Infusion, Soleo Health


Read Full Articlered right arrow icon